Shares of Elevance Health Inc. ELV rallied 1.02% to $396.88 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 1.59% to 5,954.50 and the Dow Jones Industrial Average DJIA rising 1.39% to 43,840.91.

For Elevance Health and other big insurers, 2024 devolved into something of an annus horribilis over the year’s final weeks. And 2025 holds more challenges but also an opportunity for a rebound.

Elevance Health says its acquisition of Verily’s Granular Insurance is designed to bolster its offerings to self-funded employer clients.

Over the past year, many Elevance Health, Inc. ( NYSE:ELV ) insiders sold a significant stake in the company which

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research note issued on Friday. A number of other research firms have also recently weighed in on ELV.

Buying $100 In ELV: If an investor had bought $100 of ELV stock 20 years ago, it would be worth $646.73 today based on a price of $394.70 for ELV at the time of writing.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

With a market cap of $90.6 billion, Elevance Health, Inc. (ELV ... ELV is trading below the mean price target of $485.13. The Street-high price target of $625 implies a potential upside of ...

Elevance Health, Inc. (NYSE:ELV – Get Free Report) shares gapped down before the market opened on Friday . The stock had previously closed at $390.50, but opened at $379.00. Elevance Health ...

UnitedHealth is under investigation by the Justice Department over its Medicare billing practices and how it records diagnoses. Dig deeper: